Indonesia speeds up new TB vaccine development to combat rising cases
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
The landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec.
Specifically, the team compared the immune responses in people who were protected against CMV infection after receiving the older vaccine.
For years, the human papillomavirus (HPV) vaccine has been widely recognized as a crucial weapon against cervical cancer in women.
India’s billionaire "vaccine prince" Adar Poonawalla has reached a deal for London’s most expensive home sale of the year, agreeing to pay about 138 mn pound for a 25,000 square foot Mayfair mansion, media reports said.
WHO spokesperson Margaret Harris told journalists in Geneva that at least 87 children have died due to measles this year.
The development has come after the World Health Organisation approved Covaxin for emergency use listing last week.
The majority of new infections were in Victoria, the country's second-most populous state, where 1,268 cases and seven deaths were reported.
In the same period, 221 new fatalities were reported, which increased the death toll to 4,49,873.
The approval by Australia comes when the Bharat Biotech-manufactured Covid-19 vaccine is seeking an approval from the WHO for Covaxin.
